234 related articles for article (PubMed ID: 16107310)
1. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
de Jong TR; Snaphaan LJ; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
Eur Neuropsychopharmacol; 2006 Jan; 16(1):39-48. PubMed ID: 16107310
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
[TBL] [Abstract][Full Text] [Related]
4. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
[TBL] [Abstract][Full Text] [Related]
5. Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
Vorhees CV; Morford LR; Graham DL; Skelton MR; Williams MT
Behav Brain Funct; 2011 Oct; 7():41. PubMed ID: 21974752
[TBL] [Abstract][Full Text] [Related]
6. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
[TBL] [Abstract][Full Text] [Related]
7. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Sánchez C; Hyttel J
Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
Redrobe JP; Bourin M; Colombel MC; Baker GB
J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
[TBL] [Abstract][Full Text] [Related]
9. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation.
Li Y; Pehrson AL; Oosting RS; Gulinello M; Olivier B; Sanchez C
Neuropharmacology; 2017 Jul; 121():89-99. PubMed ID: 28414050
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.
Mos J; Mollet I; Tolboom JT; Waldinger MD; Olivier B
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):123-35. PubMed ID: 10082238
[TBL] [Abstract][Full Text] [Related]
11. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
[TBL] [Abstract][Full Text] [Related]
12. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.
Waldinger MD; van De Plas A; Pattij T; van Oorschot R; Coolen LM; Veening JG; Olivier B
Psychopharmacology (Berl); 2002 Mar; 160(3):283-9. PubMed ID: 11889497
[TBL] [Abstract][Full Text] [Related]
13. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
Zanoveli JM; Nogueira RL; Zangrossi H
Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964
[TBL] [Abstract][Full Text] [Related]
14. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
Tokarski K; Bijak M
Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
[TBL] [Abstract][Full Text] [Related]
19. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
[TBL] [Abstract][Full Text] [Related]
20. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Sánchez C; Meier E
Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]